Slashdot Mirror
A Serious New Hurdle For CRISPR: Edited Cells Might Cause Cancer, Find Two Studies (statnews.com)
Editing cell genomes with CRISPR-Cas9 might increase the risk of developing cancer, two studies published Monday warn. From a report: Editing cells' genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn -- a potential game-changer for the companies developing CRISPR-based therapies. In the studies, published in Nature Medicine, scientists found that cells whose genomes are successfully edited by CRISPR-Cas9 have the potential to seed tumors inside a patient. That could make some CRISPR'd cells ticking time bombs, according to researchers from Sweden's Karolinska Institute and, separately, Novartis. CRISPR has already dodged two potentially fatal bullets -- a 2017 claim that it causes sky-high numbers of off-target effects was retracted in March, and a report of human immunity to Cas9 was largely shrugged off as solvable. But experts are taking the cancer-risk finding seriously.
I for one am shocked that gene editing can lead to a disease caused by altered genes.
I think that the scientists are unworthy of grants.
So because you don't like the results, you want to take away their grants? Are you kidding me? That's not how science works.
In any case, like you, I also hope that the results are wrong, but even if I hate the results, I just can't wish them away (assuming their results are correct, I have no idea if they are, or not).
Cancer is basically cells that went rogue. You telling me that slicing and dicing DNA (sometimes accidentally in non-target locations) can sometimes cause a cell to not do what it was suppose to? CRISPR is more targetted than say getting hit with a blast of radiation which causes random mutations but you are still changing the programming of a highly complex instruction set written in obfuscated code that we barely understand.
The article addresses this. P53 is like the ECC of the DNA. It detects errors and then either self destructs the cell or fixes the 'damage'. The concern is that CRISPR weakens the p53 response and therefore the natural Error Correction processes of the cells which normally terminate tumorous dna damage.
However, the cancer treatments using CRISPR (and several other CRISPR therapies) don't rely on p53
CRISPR-based editing of T cells to treat cancer, as scientists at the University of Pennsylvania are studying in a clinical trial, should also not have a p53 problem. Nor should any therapy developed with CRISPR base editing, which does not make the double-stranded breaks that trigger p53.